Questions about this study?
The HopeStage team will email you.
Enrolling By InvitationNCT07145593
Gamma tACS in Attention-Deficit/Hyperactivity Disorder
Device studyAges 18–40TürkiyeADHD
Understand this study
Who could participate?
Listed age limits: 18 years to 40 years.
- Listed locations
- Istanbul, Türkiye · TürkiyeSee all locations and recruitment
- Activities
- Device procedures described in the protocol · Sham comparator
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: October 1, 2025
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 60
- Sponsor
- Medipol University
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- Türkiye
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT07145593
- Official title
Show the full official title
Gamma Transcranial Alternating Current Stimulation in Attention Deficit Hyperactivity Disorder
Recruitment & locations
By invitationIstanbul, Türkiye · Türkiye
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Medipol University, a university.
Who can participate?
Listed age limits: 18 years to 40 years.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me
